Diagnosis and selection of alternative antibiotics in beta-lactams hypersensitivity reactions: Current recommendations and challenges.

[1]  J. Trubiano,et al.  Drug reaction with eosinophilia and systemic symptoms: A systematic review. , 2023, The journal of allergy and clinical immunology. In practice.

[2]  G. Porebski,et al.  In Vitro Assays for Diagnosis of Drug-Induced Nonsevere Exanthemas: A Systematic Review and Meta-Analysis , 2022, Journal of immunology research.

[3]  M. Ben-Shoshan,et al.  Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions , 2022, Frontiers in Medicine.

[4]  S. Fernando,et al.  Development and initial validation of a modified lymphocyte transformation test (LTT) assay in patients with DRESS and AGEP , 2022, Allergy, Asthma & Clinical Immunology.

[5]  R. Saff.  Skin Testing as a Biomarker in Drug Allergy. , 2022, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  A. D. de Groot.  Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review , 2022, Contact dermatitis.

[7]  A. Romano,et al.  Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions. , 2022, Immunology and allergy clinics of North America.

[8]  A. D. de Groot.  Results of patch testing in Acute generalized exanthematous pustulosis (AGEP): a literature review. , 2022, Contact dermatitis.

[9]  W. Crawford,et al.  Population-based incidence of new ampicillin, cephalexin, cefaclor, and sulfonamide antibiotic "allergies" in exposed individuals with and without preexisting ampicillin, cephalexin, or cefaclor "allergies". , 2021, The journal of allergy and clinical immunology. In practice.

[10]  Chan Sun Park,et al.  Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study , 2021, The World Allergy Organization journal.

[11]  M. Ben-Shoshan,et al.  Direct Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing. , 2021, The journal of allergy and clinical immunology. In practice.

[12]  Y. Srinoulprasert.  Lymphocyte transformation test and cytokine detection assays: Determination of read out parameters for delayed-type drug hypersensitivity reactions. , 2021, Journal of immunological methods.

[13]  G. Porebski,et al.  ELISpot assay as a diagnostic tool in drug hypersensitivity reactions. , 2021, Journal of immunological methods.

[14]  Anna C. Davis,et al.  Association Between Removal of a Warning Against Cephalosporin Use in Patients With Penicillin Allergy and Antibiotic Prescribing , 2021, JAMA network open.

[15]  E. Phillips,et al.  Skin Testing for Penicillin Allergy: a Review of the Literature , 2021, Current Allergy and Asthma Reports.

[16]  Andrew Gibson,et al.  An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity , 2021, Frontiers in Pharmacology.

[17]  M. Ben-Shoshan,et al.  Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology , 2020, Allergy, Asthma & Clinical Immunology.

[18]  Paige G. Wickner,et al.  Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. , 2020, The journal of allergy and clinical immunology. In practice.

[19]  M. Castells,et al.  Practical Guidelines for the Evaluation and Management of Drug Hypersensitivity: General Concepts. , 2020, The journal of allergy and clinical immunology. In practice.

[20]  H. Hoffmann,et al.  Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice , 2020, Allergy.

[21]  M. Tang,et al.  Minimal agreement between basophil activation test and immunoassay in diagnosis of penicillin allergy. , 2020, Allergologia et immunopathologia.

[22]  L. Delgado,et al.  Accuracy of Penicillin Allergy Diagnostic Tests: A Systematic Review and Meta-analysis. , 2020, The Journal of allergy and clinical immunology.

[23]  P. Wolkenstein,et al.  Cross‐reactivity in beta‐lactams after a non‐immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  J. Bousquet,et al.  IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper , 2020, The World Allergy Organization journal.

[25]  E. Phillips,et al.  Penicillin Allergy. , 2019, The New England journal of medicine.

[26]  P. Demoly,et al.  Towards a more precise diagnosis of hypersensitivity to beta‐lactams — an EAACI position paper , 2019, Allergy.

[27]  F. Regateiro,et al.  Epidemiology and risk factors for severe delayed drug hypersensitivity reactions. , 2019, Current pharmaceutical design.

[28]  M. Veve,et al.  Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity , 2019, Pharmacy.

[29]  P. Demoly,et al.  A EAACI drug allergy interest group survey on how European allergy specialists deal with β‐lactam allergy , 2019, Allergy.

[30]  M. Pirmohamed,et al.  Controversies in drug allergy: Testing for delayed reactions. , 2019, The Journal of allergy and clinical immunology.

[31]  A. Barbaud.  In Vitro and In Vivo Tests in Cutaneous Adverse Drug Reactions , 2018, Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions.

[32]  D. Consonni,et al.  Basophil Activation Test Application in Drug Hypersensitivity Diagnosis: An Empirical Approach , 2018, International Archives of Allergy and Immunology.

[33]  P. Meyers,et al.  Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke , 2018, American Journal of Neuroradiology.

[34]  E. Pérez-Inestrosa,et al.  Dendrimeric Antigens for Drug Allergy Diagnosis: A New Approach for Basophil Activation Tests , 2018, Molecules.

[35]  Nikolaos A. Triarides,et al.  An update on adverse drug reactions related to β-lactam antibiotics , 2018, Expert opinion on drug safety.

[36]  E. Ramírez,et al.  Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[37]  L. Moral,et al.  Oral challenge without skin tests in children with non‐severe beta‐lactam hypersensitivity: Time to change the paradigm? , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[38]  P. Eigenmann,et al.  Natural History of Benign Nonimmediate Allergy to Beta-Lactams in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test. , 2017, The journal of allergy and clinical immunology. In practice.

[39]  R. Solensky,et al.  Penicillin and Beta-Lactam Hypersensitivity. , 2017, Immunology and allergy clinics of North America.

[40]  J. Fonseca,et al.  Frequency of self-reported drug allergy: A systematic review and meta-analysis with meta-regression. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[41]  M. Torres,et al.  Use of the Basophil Activation Test May Reduce the Need for Drug Provocation in Amoxicillin-Clavulanic Allergy. , 2017, The journal of allergy and clinical immunology. In practice.

[42]  E. Pérez-Inestrosa,et al.  The Value of In Vitro Tests to DiminishDrug Challenges , 2017, International journal of molecular sciences.

[43]  Nanda Ramchandar,et al.  Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits. , 2017, The journal of allergy and clinical immunology. In practice.

[44]  M. Torres,et al.  In Vitro Diagnostic Testing for Antibiotic Allergy , 2017, Allergy, asthma & immunology research.

[45]  A. Romano,et al.  Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis , 2017, Current Allergy and Asthma Reports.

[46]  A. Trivedi,et al.  Are non‐allergic drug reactions commonly documented as medication “allergies”? A national cohort of Veterans' admissions from 2000 to 2014 , 2017, Pharmacoepidemiology and drug safety.

[47]  P. Demoly,et al.  Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America , 2017, Clinical and Translational Allergy.

[48]  D. Ebo,et al.  In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations , 2017, Drugs in R&D.

[49]  D. Bates,et al.  Drug allergies documented in electronic health records of a large healthcare system , 2016, Allergy.

[50]  E. Corsini,et al.  In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells , 2016, Front. Pharmacol..

[51]  M. Ben-Shoshan,et al.  Positive penicillin allergy testing results: a systematic review and meta-analysis of papers published from 2010 through 2015 , 2016, Postgraduate medicine.

[52]  M. Ben-Shoshan,et al.  Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children. , 2016, JAMA pediatrics.

[53]  A. Romano,et al.  Cross-Reactivity among Beta-Lactams , 2016, Current Allergy and Asthma Reports.

[54]  J. Perkins,et al.  Selective immediate responders to amoxicillin and clavulanic acid tolerate penicillin derivative administration after confirming the diagnosis , 2015, Allergy.

[55]  I. James,et al.  Improving the Effectiveness of Penicillin Allergy De-labeling. , 2015, The journal of allergy and clinical immunology. In practice.

[56]  E. Novembre,et al.  Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions. , 2015, Journal of Allergy and Clinical Immunology: In Practice.

[57]  P. Eigenmann,et al.  Skin tests and in vitro allergy tests have a poor diagnostic value for benign skin rashes due to β‐lactams in children , 2015, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[58]  M. Pirmohamed,et al.  Management of allergy to penicillins and other beta‐lactams , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[59]  P. Bégin,et al.  Skin testing only with penicillin G in children with a history of penicillin allergy. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[60]  C. Chiu,et al.  Severe cutaneous adverse reactions related to systemic antibiotics. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  M. Pichichero,et al.  Penicillin and cephalosporin allergy. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[62]  M. Blanca,et al.  Diagnostic evaluation of hypersensitivity reactions to beta‐lactam antibiotics in a large population of children , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[63]  A. Romano,et al.  Absence of cross‐reactivity to carbapenems in patients with delayed hypersensitivity to penicillins , 2013, Allergy.

[64]  C. Petrişor,et al.  Basophil activation test versus radio-immunoassay in the diagnosis of β-lactam immediate-type hypersensitivity reactions , 2013 .

[65]  W. Pichler,et al.  In vitro drug causality assessment in Stevens–Johnson syndrome – alternatives for lymphocyte transformation test , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[66]  K. Aouam,et al.  Fixed drug eruption: a selective reaction to amoxicillin. , 2013, Therapie.

[67]  E. Macy,et al.  Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. , 2013, The journal of allergy and clinical immunology. In practice.

[68]  A. Buonomo,et al.  Tolerability of Aztreonam in Patients with Cell-Mediated Allergy to β-Lactams , 2010, International Archives of Allergy and Immunology.

[69]  A. Barbaud.  Skin testing in delayed reactions to drugs. , 2009, Immunology and allergy clinics of North America.

[70]  G. Stingl,et al.  SDRIFE (baboon syndrome) induced by penicillin , 2009, Clinical and experimental dermatology.

[71]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[72]  James T.C. Li,et al.  Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[73]  A. Buonomo,et al.  Delayed Allergy to Aminopenicillins: Clinical and Immunological Findings , 2006, International journal of immunopathology and pharmacology.

[74]  R. Pettinato,et al.  Imipenem in patients with immediate hypersensitivity to penicillins. , 2006, The New England journal of medicine.

[75]  Na Gao,et al.  HLA-DRB genotype and specific IgE responses in patients with allergies to penicillins. , 2006, Chinese medical journal.

[76]  W. Pichler,et al.  Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. , 2006, The Journal of allergy and clinical immunology.

[77]  P. Bousquet,et al.  Diagnosing nonimmediate reactions to cephalosporins. , 2005, The Journal of allergy and clinical immunology.

[78]  A. Casillas,et al.  Adverse drug reactions: types and treatment options. , 2003, American family physician.

[79]  R. Gruchalla.  Drug metabolism, danger signals, and drug-induced hypersensitivity. , 2001, The Journal of allergy and clinical immunology.

[80]  L. Larocca,et al.  Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[81]  A. Romano,et al.  Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics , 1999 .

[82]  A. Kappeler,et al.  Drug‐induced papulovesicular exanthema , 1998, Allergy.

[83]  A. Romano,et al.  Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[84]  M. Blanca,et al.  Cross-reactivity between a penicillin and a cephalosporin with the same side chain. , 1996, The Journal of allergy and clinical immunology.

[85]  G. Beall,et al.  Immediate hypersensitivity reactions to beta-lactam antibiotics. , 1987, Annals of internal medicine.

[86]  K. Neftel,et al.  Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro , 1984, Klinische Wochenschrift.

[87]  B. Levine.  Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. , 1966, The New England journal of medicine.

[88]  J. Shih,et al.  Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy. , 2019, Allergy and asthma proceedings.

[89]  M. Torres,et al.  Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing. , 2019, The journal of allergy and clinical immunology. In practice.

[90]  A. Romano,et al.  HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping. , 2015, The Journal of allergy and clinical immunology.

[91]  M. Blanca,et al.  Hypersensitivity reactions to β-lactams: relevance of hapten-protein conjugates. , 2015, Journal of investigational allergology & clinical immunology.

[92]  A. Buonomo,et al.  Cross-reactivity and tolerability of cephalosporins in patients with cell-mediated allergy to penicillins. , 2014, Journal of investigational allergology & clinical immunology.

[93]  M. Carroll,et al.  Fixed drug eruption: Aztreonam and ceftazidime cross-reactivity in cystic fibrosis, a case report , 2010 .

[94]  R. Confino‐Cohen,et al.  Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[95]  Z. Pourpak,et al.  Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects. , 2008, Recent patents on inflammation & allergy drug discovery.

[96]  H. S. Earl,et al.  Safety of cephalosporin administration to patients with histories of penicillin allergy. , 2004, The Journal of allergy and clinical immunology.

[97]  M. Kempe,et al.  Synthesis and screening of a molecularly imprinted polymer library targeted for penicillin G. , 2003, Journal of combinatorial chemistry.

[98]  R. Moss,et al.  Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis. , 1991, The Journal of allergy and clinical immunology.